Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 3. Rapid correction of low vitamin D status in nursing home residents 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
Estimated age- and sex-specific incidence and prevalence of dopamine agonist-treated hyperprolactinemia
Journal of Clinical Endocrinology and Metabolism, 06/15/09
Kars M et al. - The incidence rates and the prevalence of dopamine agonist - treated hyperprolactinemia showed an overall preponderance in women, with a strong peak for women aged 25–34 years. In men no peak was found.
Related Articles
Recurrence of Hyperprolactinemia after Withdrawal of Dopamine Agonists: Systematic Review and Meta-Analysis
Journal of Clinical Endocrinology and Metabolism, 11/20/09
Relevance Score: 85%
Metabolic and Cardiac Side Effects of Second-generation Antipsychotics: What Every Clinician Should Know
Journal of Pharmacy Practice, 11/05/09
Relevance Score: 80%
Galactorrhea associated with juvenile systemic lupus erythematosus: a review of the role of prolactin
Pediatric Rheumatology, 10/26/09
Relevance Score: 80%
Prolactinoma in Children and Adolescents
Hormone Research, 10/07/09
Relevance Score: 80%
Today in Reproductive Endocrinology...keeping you current
Receive free subspecialty "5-minute updates" via email
Associations of Birthweight and Gestational Age with Reproductive and Metabolic Phenotypes in Women with Polycystic Ovarian Syndrome and Their First-Degree Relatives
Journal of Clinical Endocrinology and Metabolism, 12/17/09
Metformin Reduces Arterial Stiffness and Improves Endothelial Function in Young Women with Polycystic Ovary Syndrome: A Randomized, Placebo-Controlled, Crossover Trial
Journal of Clinical Endocrinology and Metabolism, 12/17/09
A new FSHbeta mutation in a 29 year-old woman with primary amenorrhea and isolated FSH deficiency: functional characterization and ovarian response to human recombinant FSH
European Journal of Endocrinology, 12/16/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


